Showing 1,301 - 1,320 results of 118,418 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( a ((nn decrease) OR (mean decrease)) ))', query time: 1.43s Refine Results
  1. 1301
  2. 1302
  3. 1303
  4. 1304
  5. 1305
  6. 1306
  7. 1307
  8. 1308
  9. 1309

    Inhibition of MRP1 significantly decreases basal and apoptotic GSH efflux. by Parameswaran G. Sreekumar (176748)

    Published 2012
    “…GSH release from MRP1-silenced ARPE-19 cells incubated with 150 µM H<sub>2</sub>O<sub>2</sub> for 5 h in serum free medium. A significant decrease (P<0.001 vs scrambled control) in GSH release was observed in 5 h. …”
  10. 1310
  11. 1311

    Nilotinib decreases the <i>in vitro</i> tumorigenicity of HEI-193 cells. by Nesrin Sabha (127278)

    Published 2013
    “…(C) The mean maximal colony diameter was decreased by nilotinib at ≥3 µM in PDGF-BB media, and at ≥5 µM in GM. …”
  12. 1312
  13. 1313
  14. 1314
  15. 1315
  16. 1316

    L-NNA treatment decreases tumor blood flow and increases hypoxia. by Robert J. G. Cardnell (350872)

    Published 2013
    “…Data presented as mean intensity as a percentage of control ± SEM; n = 5; *** = p<0.01. …”
  17. 1317
  18. 1318
  19. 1319
  20. 1320

    SH-11052 decreases the expression of NF-κB target genes. by Halesha D. Basavarajappa (534825)

    Published 2014
    “…(C) qRT-PCR using TaqMan probes showed that mRNA levels of NF-κB target genes <i>IL8</i> (interleukin-8) (<i>left panel</i>), <i>CCL2</i> (MCP-1) and <i>PTGS2</i> (COX2) (<i>right panel</i>), all induced by TNF-α, were decreased in the presence of <b>2</b> in a dose dependent manner. …”